mojo47
- 09 Sep 2003 21:17
Any thoughts on xen. I know that they were 4.50ish a few years ago. I bought them a few months ago at 17p so they owe me a bit of money.
Thanks mary
mwoolgar
- 27 Apr 2004 21:08
- 14 of 31
what is WSJ article
Oakapples142
- 22 Sep 2004 14:41
- 15 of 31
Now chat for nearly 6 months - think I may be hooked into another PXC - buys allday (admittedly low volume) but the SP goes down. Anyone watching this and may have an update?
maddoctor
- 22 Sep 2004 16:40
- 16 of 31
look at the last two trades!
Oakapples142
- 22 Sep 2004 16:51
- 17 of 31
maddoctor - thanks - I noticed - I cannot get use to play after hours - not cricket - however, SP returned to opening level
piston broke
- 13 Jan 2005 08:37
- 18 of 31
Morning Guys...potential 45m order, so looks like they are on the move after all these years and up 25% ish today
Be Lucky...p b
sandrew64
- 13 Jan 2005 08:48
- 19 of 31
Wow.......sold these ages ago, but hung on to the warrants just in case!
Fred1new
- 13 Jan 2005 14:05
- 20 of 31
Announced to-day;-
"UK smallcap opening - Xenova up on Oxxon deal
AFX
LONDON (AFX) - Xenova jumped 18.5 pct - or 1.25 to 8.00 pence - in response to news that the company has licensed its DISC vector, and vaccines developed using it, to Oxxon Therapeutics, a private biotech company based in Oxford, UK and Boston, US.
Simon Fazeli on Nomura adopted a 'neutral' stance on the stock following the news, taking the view that Xenova is trying to extract the best value that it can from projects that it is no longer funding.
He added that the key issue for Xenova remains its funding needs, which according to his model, become critical around the middle of this year.
The company may be able to delay its needs by out-licensing its addiction vaccines and raising enough cash to allow it to operate until the interim data from the first Phase 111 trial of TransMID are available, ie around the end of the year, Fazeli said.
If these are positive, it should then be able to raise money a lot easier, he concluded.
fjb/slm/
""""Xenova signs exclusive licensing agreement with Oxxon worth up to 44 mln stg
AFX
LONDON (AFX) - Xenova Group PLC said it has signed an exclusive licensing agreement with Oxxon Therapeutics Ltd potentially worth up to 44 mln stg in up front and milestone payments, in addition to royalties on product sales.
The agreement provides Oxxon with the right to use the DISC-HSV Vector (Disabled Infectious Single Cycle - Herpes Simplex Virus) in a number of specified indications in the areas of oncology and infectious diseases.
Oxxon also has the option to further, as yet unspecified, indications subject to payment of additional fees.
newsdesk@afxnews.com
"""
IF IF this is successful, the sky is the limit. If not ??
I have a small hholing in these, wish it was bigger. No cash. No real dogs, just pups waiting to mature.
pachandl
- 13 Jan 2005 15:59
- 21 of 31
BANKONE
- 24 Jan 2005 22:43
- 22 of 31
Can anyone explain to me as to whether someone or some institution bought or dumped 24.6m shares at 8.25p after the bell today.
BANKONE
- 25 Jan 2005 09:30
- 23 of 31
Another 21m shares at 8.25p reported this morning and time shown as 1654 is this another case of mms manipulating the price to keep it artificially low or are there some big buyers about/orders to fill or again is it some serious dumping.
StarFrog
- 25 Jan 2005 09:41
- 24 of 31
Hmmm. Very strange.
But if it brings the price down, look at it as a buying opportunity Bankone.
I've held these chaps for a long time now and have no intention of ditching them in the near future. This company is developing the 'right' sort of drugs as far as investors are concerned - i.e. drugs to combat addiction with a strong PR. Can you imagine the sales if they can produce a pill that will help stop smoking! The media will love that. Unlimited press coverage.
Fred1new
- 16 May 2005 17:40
- 26 of 31
Driver, Come on, Smoking cuts down pension costs.
Fred1new
- 17 May 2005 01:17
- 28 of 31
That would push the share price up.
driver
- 17 May 2005 08:50
- 30 of 31